{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:13:07Z","timestamp":1780981987392,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the project of Guangxi Autonomous Region Education Department","award":["2020KY07031"],"award-info":[{"award-number":["2020KY07031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10528-024-10684-x","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T19:02:27Z","timestamp":1709578947000},"page":"281-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats"],"prefix":"10.1007","volume":"63","author":[{"given":"Xinyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiabing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"3","key":"10684_CR1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0016-5085(92)90179-3","volume":"102","author":"A Albillos","year":"1992","unstructured":"Albillos A, Colombato LA, Groszmann RJ (1992) Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 102(3):931\u2013935","journal-title":"Gastroenterology"},{"issue":"1","key":"10684_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-017-0966-6","volume":"15","author":"A Berzigotti","year":"2017","unstructured":"Berzigotti A (2017) Advances and challenges in cirrhosis and portal hypertension. BMC Med 15(1):200","journal-title":"BMC Med"},{"issue":"2","key":"10684_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/path.1700750212","volume":"75","author":"GR Cameron","year":"1958","unstructured":"Cameron GR, Muzaffar Hasan S (1958) Disturbances of structure and function in the liver as the result of biliary obstruction. J Pathol Bacteriol 75(2):333\u2013349","journal-title":"J Pathol Bacteriol"},{"issue":"5","key":"10684_CR4","first-page":"G371","volume":"240","author":"M Chojkier","year":"1981","unstructured":"Chojkier M, Groszmann RJ (1981) Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 240(5):G371\u2013G375","journal-title":"Am J Physiol"},{"issue":"9","key":"10684_CR5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/mt.2014.102","volume":"22","author":"HC Chong","year":"2014","unstructured":"Chong HC et al (2014) Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice. Mol Ther 22(9):1593\u20131604","journal-title":"Mol Ther"},{"key":"10684_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molimm.2020.05.017","volume":"124","author":"S Chun-Bin","year":"2020","unstructured":"Chun-Bin S et al (2020) The main active components of curcuma zedoaria reduces collagen deposition in human lung fibroblast via autophagy. Mol Immunol 124:109\u2013116","journal-title":"Mol Immunol"},{"issue":"2","key":"10684_CR7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","volume":"31","author":"S Coulon","year":"2011","unstructured":"Coulon S et al (2011) Angiogenesis in chronic liver disease and its complications. Liver Int 31(2):146\u2013162","journal-title":"Liver Int"},{"issue":"3","key":"10684_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4254\/wjh.v7.i3.377","volume":"7","author":"G Elpek","year":"2015","unstructured":"Elpek G (2015) Angiogenesis and liver fibrosis. World J Hepatol 7(3):377\u2013391","journal-title":"World J Hepatol"},{"issue":"4","key":"10684_CR9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","volume":"46","author":"M Fernandez","year":"2007","unstructured":"Fernandez M et al (2007) Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 46(4):1208\u20131217","journal-title":"Hepatology"},{"issue":"7","key":"10684_CR10","doi-asserted-by":"crossref","first-page":"e69309","DOI":"10.1371\/journal.pone.0069309","volume":"8","author":"JH Gao","year":"2013","unstructured":"Gao JH et al (2013) Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. PLoS ONE 8(7):e69309","journal-title":"PLoS ONE"},{"issue":"4","key":"10684_CR11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10456-016-9522-9","volume":"19","author":"JH Gao","year":"2016","unstructured":"Gao JH et al (2016) Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis 19(4):501\u2013511","journal-title":"Angiogenesis"},{"key":"10684_CR12","doi-asserted-by":"crossref","first-page":"152707","DOI":"10.1016\/j.tox.2021.152707","volume":"452","author":"L Gao","year":"2021","unstructured":"Gao L et al (2021) Autophagy-induced p62 accumulation is required for curcumol to regulate KLF5-mediated angiogenesis in liver sinusoidal endothelial cells. Toxicology 452:152707","journal-title":"Toxicology"},{"issue":"20","key":"10684_CR13","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.3748\/wjg.v21.i20.6117","volume":"21","author":"DV Garbuzenko","year":"2015","unstructured":"Garbuzenko DV (2015) Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J Gastroenterol 21(20):6117\u20136126","journal-title":"World J Gastroenterol"},{"issue":"16","key":"10684_CR14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4254\/wjh.v8.i16.665","volume":"8","author":"DV Garbuzenko","year":"2016","unstructured":"Garbuzenko DV, Arefyev NO, Belov DV (2016) Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World J Hepatol 8(16):665\u2013672","journal-title":"World J Hepatol"},{"issue":"33","key":"10684_CR15","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.3748\/wjg.v24.i33.3738","volume":"24","author":"DV Garbuzenko","year":"2018","unstructured":"Garbuzenko DV, Arefyev NO, Kazachkov EL (2018) Antiangiogenic therapy for portal hypertension in liver cirrhosis: current progress and perspectives. World J Gastroenterol 24(33):3738\u20133748","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10684_CR16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.27117","volume":"60","author":"M Granzow","year":"2014","unstructured":"Granzow M et al (2014) Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis. Hepatology 60(1):334\u2013348","journal-title":"Hepatology"},{"issue":"2","key":"10684_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/01635581.2020.1749676","volume":"73","author":"S Hashem","year":"2021","unstructured":"Hashem S et al (2021) Therapeutic effects of curcumol in several diseases; an overview. Nutr Cancer 73(2):181\u2013195","journal-title":"Nutr Cancer"},{"key":"10684_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6:425\u2013456","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10684_CR19","first-page":"H1150","volume":"276","author":"D Hodeige","year":"1999","unstructured":"Hodeige D et al (1999) On the validity of blood flow measurement using colored microspheres. Am J Physiol 276(4):H1150\u2013H1158","journal-title":"Am J Physiol"},{"issue":"3","key":"10684_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00109-019-01746-4","volume":"97","author":"L Hu","year":"2019","unstructured":"Hu L et al (2019) AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. J Mol Med 97(3):423\u2013434","journal-title":"J Mol Med"},{"issue":"1","key":"10684_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hep.25625","volume":"56","author":"HC Huang","year":"2012","unstructured":"Huang HC et al (2012) Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. Hepatology 56(1):248\u2013258","journal-title":"Hepatology"},{"issue":"4","key":"10684_CR22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.ajpath.2011.06.045","volume":"179","author":"RC Huebert","year":"2011","unstructured":"Huebert RC et al (2011) Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs. Am J Pathol 179(4):1851\u20131860","journal-title":"Am J Pathol"},{"key":"10684_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.redox.2018.09.007","volume":"19","author":"Y Jia","year":"2018","unstructured":"Jia Y et al (2018) Curcumol induces RIPK1\/RIPK3 complex-dependent necroptosis via JNK1\/2-ROS signaling in hepatic stellate cells. Redox Biol 19:375\u2013387","journal-title":"Redox Biol"},{"key":"10684_CR24","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2147\/DDDT.S292642","volume":"15","author":"S Jia","year":"2021","unstructured":"Jia S et al (2021) Curcumol ameliorates lung inflammation and airway remodeling via inhibiting the abnormal activation of the Wnt\/\u03b2-catenin pathway in chronic asthmatic mice. Drug Des Devel Ther 15:2641\u20132651","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10684_CR25","first-page":"305","volume":"65","author":"J Kountouras","year":"1984","unstructured":"Kountouras J, Billing BH, Scheuer PJ (1984) Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65(3):305\u2013311","journal-title":"Br J Exp Pathol"},{"issue":"5","key":"10684_CR26","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","volume":"44","author":"RY Liu","year":"2014","unstructured":"Liu RY et al (2014) JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol 44(5):1643\u20131651","journal-title":"Int J Oncol"},{"issue":"4","key":"10684_CR27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.33549\/physiolres.934626","volume":"70","author":"M Lunova","year":"2021","unstructured":"Lunova M et al (2021) Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis. Physiol Res 70(4):563\u2013577","journal-title":"Physiol Res"},{"issue":"4","key":"10684_CR28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","volume":"49","author":"M Mejias","year":"2009","unstructured":"Mejias M et al (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49(4):1245\u20131256","journal-title":"Hepatology"},{"issue":"2","key":"10684_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/gut.2008.155028","volume":"58","author":"P Melgar-Lesmes","year":"2009","unstructured":"Melgar-Lesmes P et al (2009) Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats. Gut 58(2):285\u2013292","journal-title":"Gut"},{"issue":"2","key":"10684_CR30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1534735416642865","volume":"15","author":"L Ning","year":"2016","unstructured":"Ning L et al (2016) Curcumol suppresses breast cancer cell metastasis by inhibiting MMP-9 Via JNK1\/2 and Akt-dependent NF-\u03baB signaling pathways. Integr Cancer Ther 15(2):216\u2013225","journal-title":"Integr Cancer Ther"},{"issue":"14","key":"10684_CR31","volume":"36","author":"JW Park","year":"2021","unstructured":"Park JW et al (2021) Increased expression of S100B and rage in a mouse model of bile duct ligation-induced liver fibrosis. J Korean Med Sci 36(14):e90","journal-title":"J Korean Med Sci"},{"key":"10684_CR32","doi-asserted-by":"crossref","first-page":"912825","DOI":"10.3389\/fphar.2022.912825","volume":"13","author":"X Qi","year":"2022","unstructured":"Qi X et al (2022) Curcumol suppresses CCF-mediated hepatocyte senescence through blocking LC3B-Lamin B1 interaction in alcoholic fatty liver disease. Front Pharmacol 13:912825","journal-title":"Front Pharmacol"},{"issue":"5","key":"10684_CR33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","volume":"51","author":"T Reiberger","year":"2009","unstructured":"Reiberger T et al (2009) Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. J Hepatol 51(5):865\u2013873","journal-title":"J Hepatol"},{"issue":"4","key":"10684_CR34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF (2020) Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 9(4):875","journal-title":"Cells"},{"issue":"3","key":"10684_CR35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.18632\/oncotarget.234","volume":"2","author":"RS Samant","year":"2011","unstructured":"Samant RS, Shevde LA (2011) Recent advances in anti-angiogenic therapy of cancer. Oncotarget 2(3):122\u2013134","journal-title":"Oncotarget"},{"issue":"6","key":"10684_CR36","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2014.01.025","volume":"60","author":"P Schwabl","year":"2014","unstructured":"Schwabl P et al (2014) Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats. J Hepatol 60(6):1135\u20131142","journal-title":"J Hepatol"},{"key":"10684_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8197","author":"W Sheng","year":"2021","unstructured":"Sheng W et al (2021) Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1\/AKT\/mTOR pathway by targeting miR-9. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2021.8197","journal-title":"Oncol Rep"},{"key":"10684_CR38","doi-asserted-by":"crossref","first-page":"e13376","DOI":"10.7717\/peerj.13376","volume":"10","author":"S Sun","year":"2022","unstructured":"Sun S et al (2022) Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1\/NICD pathway. PeerJ 10:e13376","journal-title":"PeerJ"},{"issue":"6","key":"10684_CR39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc2152","volume":"7","author":"HM Verheul","year":"2007","unstructured":"Verheul HM, Pinedo HM (2007) Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Nat Rev Cancer 7(6):475\u2013485","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10684_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.dld.2014.12.017","volume":"47","author":"D Wang","year":"2015","unstructured":"Wang D et al (2015) Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats. Dig Liver Dis 47(4):315\u2013323","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10684_CR41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/jgh.13207","volume":"31","author":"D Wang","year":"2016","unstructured":"Wang D et al (2016) Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis. J Gastroenterol Hepatol 31(5):1037\u20131044","journal-title":"J Gastroenterol Hepatol"},{"key":"10684_CR42","first-page":"e934914","volume":"28","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) Curcumol attenuates endometriosis by inhibiting the JAK2\/STAT3 signaling pathway. Med Sci Monit 28:e934914","journal-title":"Med Sci Monit"},{"key":"10684_CR43","doi-asserted-by":"crossref","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P et al (2020) The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 80:106210","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10684_CR44","doi-asserted-by":"crossref","first-page":"e12762","DOI":"10.1111\/cpr.12762","volume":"53","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis-PROX1-HIF-1\u03b1 in liver fibrosis. Cell Prolif 53(3):e12762","journal-title":"Cell Prolif"},{"issue":"4","key":"10684_CR45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3892\/ol.2021.12560","volume":"21","author":"D Yu","year":"2021","unstructured":"Yu D et al (2021a) Curcumol inhibits the viability and invasion of colorectal cancer cells via miR-30a-5p and Hippo signaling pathway. Oncol Lett 21(4):299","journal-title":"Oncol Lett"},{"key":"10684_CR46","doi-asserted-by":"crossref","first-page":"113442","DOI":"10.1016\/j.jep.2020.113442","volume":"266","author":"T Yu","year":"2021","unstructured":"Yu T et al (2021b) Anti-inflammation effect of Qingchang suppository in ulcerative colitis through JAK2\/STAT3 signaling pathway in vitro and in vivo. J Ethnopharmacol 266:113442","journal-title":"J Ethnopharmacol"},{"key":"10684_CR47","doi-asserted-by":"crossref","first-page":"1032722","DOI":"10.3389\/fnut.2022.1032722","volume":"9","author":"Z Yuan","year":"2022","unstructured":"Yuan Z et al (2022) Triptolide increases resistance to bile duct ligation-induced liver injury and fibrosis in mice by inhibiting RELB. Front Nutr 9:1032722","journal-title":"Front Nutr"},{"key":"10684_CR48","doi-asserted-by":"crossref","first-page":"9912776","DOI":"10.1155\/2022\/9912776","volume":"2022","author":"R Zhang","year":"2022","unstructured":"Zhang R et al (2022) A study on curcumol influencing proliferation and apoptosis of hepatocellular carcinoma cells through DJ-1\/PTEN\/PI3K\/AKT pathway. Biomed Res Int 2022:9912776","journal-title":"Biomed Res Int"},{"key":"10684_CR49","doi-asserted-by":"crossref","first-page":"8590638","DOI":"10.1155\/2020\/8590638","volume":"2020","author":"Y Zheng","year":"2020","unstructured":"Zheng Y et al (2020) Effect of curcumol on the fenestrae of liver sinusoidal endothelial cells based on NF-\u03baB signaling pathway. Evid Based Complem Alternat Med 2020:8590638","journal-title":"Evid Based Complem Alternat Med"},{"key":"10684_CR50","doi-asserted-by":"crossref","first-page":"4973128","DOI":"10.1155\/2016\/4973128","volume":"2016","author":"Y Zhou","year":"2016","unstructured":"Zhou Y et al (2016) Two traditional chinese medicines curcumae radix and curcumae rhizoma: an ethnopharmacology, phytochemistry, and pharmacology review. Evid Based Complem Alternat Med 2016:4973128","journal-title":"Evid Based Complem Alternat Med"},{"key":"10684_CR51","doi-asserted-by":"crossref","first-page":"112835","DOI":"10.1016\/j.jep.2020.112835","volume":"257","author":"HX Zuo","year":"2020","unstructured":"Zuo HX et al (2020) Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1\u03b1 and STAT3 (T705) signaling pathways in hepatic cancer. J Ethnopharmacol 257:112835","journal-title":"J Ethnopharmacol"}],"updated-by":[{"DOI":"10.1007\/s10528-025-11023-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000}}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10684-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T22:57:39Z","timestamp":1739833059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10684-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10684"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10684-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10528-025-11023-4","asserted-by":"object"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Ethical approval statement in the article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10528-025-11023-4","URL":"https:\/\/doi.org\/10.1007\/s10528-025-11023-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All animal procedures were approved by the Ethics Committee of Wuhan Myhalic Biotechnology Co., Ltd (approval number: HLK-202203125; approval date: March 14th, 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}